Abstract | BACKGROUND: METHODS: The circ-DLG1 expression levels were detected by real-time quantitative reverse transcription-polymerase chain reaction in cells, tissues, and plasmas. The correlation between circ-DLG1 expression and clinicopathologic features was then analyzed. The effect of circ-DLG1 expression on cell proliferation was evaluated in vitro by CCK8 assay and clone formation experiment. Finally, a network of circ-DLG1 with its targeted miRNA interactions and corresponding mRNAs was constructed. RESULTS: circ-DLG1was found to be significantly upregulated in ESCC cells, tissues, and plasmas compared to normal cases. Furthermore, in vitro assays, TE10 and KYSE180, of the ESCC cell lines demonstrated that knockdown of circ-DLG1 reduced cell proliferation significantly. Prediction and annotation revealed that circ-DLG1 was able to sponge to 20 miRNAs and 60 corresponding target mRNAs. CONCLUSION: Our study indicated that upregulation of circ-DLG1 promoted esophageal cell proliferation ability and might serve as a novel biomarker for ESCC.
|
Authors | Jun Rong, Qian Wang, Yanzhou Zhang, Daolong Zhu, Handong Sun, Weiwei Tang, Rongping Wang, Weihong Shi, Xiu-Feng Cao |
Journal | OncoTargets and therapy
(Onco Targets Ther)
Vol. 11
Pg. 6723-6730
( 2018)
ISSN: 1178-6930 [Print] New Zealand |
PMID | 30349305
(Publication Type: Journal Article)
|